UNICHEMLAB530.00

Unichem Laboratories Limited

· Pharma & Health
₹ CrorePeersGUFICBIORPGLIFEGUJTHEMSMSPHARMAORCHPHARMAINDSWFTLABSOLARAFDCMcap ₹3,731 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment1,194.41,279.31,203.71,203.7
+ Capital Work-in-Progress122.730.7100.1100.1
+ Goodwill1.51.61.61.6
+ Other Intangibles0.018.77.37.3
+ Non-current Investments0.00.00.00.0
+ Long-term Loans0.10.10.10.1
+ Other Non-current Financial Assets5.98.38.68.6
Non-current Financial Assets6.08.48.78.7
+ Deferred Tax Assets6.825.830.630.6
+ Other Non-current Assets140.3167.0184.9184.9
Total Non-current Assets1,471.81,531.51,536.91,536.9
Current Assets
+ Inventories704.7988.7975.0975.0
+ Current Investments1.30.00.00.0
+ Trade Receivables610.4778.8828.6828.6
+ Cash & Cash Equivalents150.989.6289.5289.5
+ Other Bank Balances3.428.15.25.2
+ Short-term Loans0.00.10.10.1
+ Other Current Financial Assets0.24.84.44.4
Current Financial Assets766.3901.31,127.81,127.8
+ Other Current Assets223.2139.494.694.6
Total Current Assets1,694.22,029.52,197.32,197.3
Total Assets3,169.33,569.43,737.43,737.4
Equity
+ Equity Share Capital14.114.114.114.1
+ Other Equity / Reserves2,348.32,436.52,703.42,703.4
Equity — Owners of Parent2,362.42,450.62,717.42,717.4
Total Equity2,362.42,450.62,717.42,717.4
Liabilities
+ Borrowings — Non-current38.260.839.139.1
+ Other Non-current Financial Liab24.225.226.026.0
Non-current Financial Liabilities62.486.065.165.1
+ Provisions — Non-current35.837.928.628.6
+ Deferred Tax Liabilities0.00.039.939.9
+ Other Non-current Liabilities0.93.00.40.4
Non-current Liabilities99.0126.8134.1134.1
+ Borrowings — Current180.9369.2429.7429.7
+ Trade Payables299.4402.6356.6356.6
+ Other Current Financial Liab33.455.365.065.0
Current Financial Liabilities513.7827.0851.3851.3
+ Provisions — Current135.9137.64.74.7
+ Current Tax Liabilities2.24.3
+ Other Current Liabilities56.123.029.929.9
Current Liabilities707.9992.0885.9885.9
Total Liabilities806.91,118.81,020.01,020.0
Total Equity & Liabilities3,169.33,569.43,737.43,737.4
Assets — additional as-filed lines
+ Non-current Assets Held for Sale3.38.53.33.3
Trade Payables — MSME split
+ Dues to Micro & Small — Current7.715.015.0
+ Dues to Other Creditors — Current394.9341.7341.7
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.